Trial NCT02500927

View at ClinicalTrials.gov 
Org. Study IDs: 8273-CL-0202

Last trial update was posted on 2018-10-23

MeSH Interventions

Naquotinib

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

EGFR-TKI-naïve Patients With NSCLC Harboring EGFR Activating Mutations

Stopping Reasons

Following recommendation by SOLAR Study IDMC, Astellas closed enrollment in ASP8273 studies.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID